Physician profile
Dennis Chong
NPI 1952353435
$5,238.75
in general payments reported to CMS, 2019-2025
20 companies · $302 in 2025
The $302 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,102 · 2021: $22.71 · 2022: $233 · 2023: $615 · 2024: $965 · 2025: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,873 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,873.08 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,573.82 | 2019-2024 | |
| Janssen Biotech, INC. | $453.68 | 2022-2025 | Stelara, Simponi, Simponi Aria |
| Genzyme Corporation | $264.40 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $219.24 | 2022-2024 | Entyvio, Gattex |
| Davol INC. | $123.60 | 2022 | |
| Qol Medical, LLC | $80.92 | 2023-2024 | Sucraid, Sucraid |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $80.32 | 2022-2024 | Xifaxan, Plenvu |
| Organon LLC | $73.92 | 2024-2025 | Hadlima |
| Redhill Biopharma INC. | $56.00 | 2022-2024 | Talicia, Movantik, Aemcolo |
| Merck Sharp & Dohme LLC | $55.91 | 2023-2024 | Dificid, Zerbaxa |
| Lilly USA, LLC | $51.63 | 2024-2025 | Omvoh |
| Intercept Pharmaceuticals, INC. | $37.50 | 2023 | Ocaliva |
| Ipsen Biopharmaceuticals, INC | $24.77 | 2025 | Iqirvo |
| Ethicon US, LLC | $24.44 | 2025 | Echelon; Endopath |
| Mallinckrodt Enterprises LLC | $23.20 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $22.72 | 2025 | Voquezna |
| Pacira Pharmaceuticals Incorporated | $22.71 | 2021 | |
| Lucid Diagnostics INC. | $21.55 | 2024 | |
| Exact Sciences Corporation | $15.90 | 2023 | Cologuard Collection Kit |
| Nestle Healthcare Nutrition INC. | $12.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Chong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.